Optina Diagnostics develops technology for the early detection of disease through the eye.
Optina Diagnostics has raised $2.1M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Optina Diagnostics's investors include Real Ventures, AQC Capital, Creative Destruction Lab, Boehringer Ingelheim Venture Fund, Desjardins Venture Capital.
Optina Diagnostics is headquartered in Saint Laurent, Canada.
Optina Diagnostics develops technology for the early detection of disease through the eye.
Optina Diagnostics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optina Diagnostics — Funding & Investors." VCBacked, January 24, 2022, https://www.vcbacked.co/company/optina-diagnostics. Accessed August 14, 2026.
VCBacked. (2022). Optina Diagnostics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/optina-diagnostics
{{cite web |title=Optina Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/optina-diagnostics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated